阿拉斯加慢性丙型肝炎病毒感染原住民患者的关怀级联：全州范围内高关联度的治疗项目。
Cascade of Care for Alaska Native People With Chronic Hepatitis C Virus Infection: Statewide Program With High Linkage to Care.
机构信息
Liver Disease and Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska.
Arctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska.
出版信息
Clin Infect Dis. 2020 Apr 15;70(9):2005-2007. doi: 10.1093/cid/ciz832.
Abstract
Most persons with chronic hepatitis C virus (HCV) infection in the United States are undiagnosed or linked to care. We describe a program for the management of Alaska Native patients infection utilizing a computerized registry and statewide liver clinics resulting in higher linkage to care (86%) than national estimates (~25%).
摘要
美国大多数慢性丙型肝炎病毒 (HCV) 感染者未被诊断或与医疗服务建立联系。我们描述了一个利用计算机化登记系统和全州肝脏诊所来管理阿拉斯加原住民患者感染的项目，其与医疗服务建立联系的比例（86%）高于全国估计值（~25%）。
相似文献
1
Cascade of Care for Alaska Native People With Chronic Hepatitis C Virus Infection: Statewide Program With High Linkage to Care.阿拉斯加慢性丙型肝炎病毒感染原住民患者的关怀级联：全州范围内高关联度的治疗项目。
Clin Infect Dis. 2020 Apr 15;70(9):2005-2007. doi: 10.1093/cid/ciz832.
2
Mortality among Alaska Native Adults with Confirmed Hepatitis C Virus Infection Compared with the General Population in Alaska, 1995-2016.1995-2016 年期间，与阿拉斯加普通人群相比，确诊丙型肝炎病毒感染的阿拉斯加原住民成年人的死亡率。
Can J Gastroenterol Hepatol. 2022 Feb 8;2022:2573545. doi: 10.1155/2022/2573545. eCollection 2022.
3
Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.丙型肝炎病毒3型感染是终末期肝病、肝细胞癌和肝脏相关死亡的独立危险因素。
Clin Gastroenterol Hepatol. 2017 Mar;15(3):431-437.e2. doi: 10.1016/j.cgh.2016.10.012. Epub 2016 Oct 17.
4
Hepatitis C-Related Mortality Among American Indian/Alaska Native Persons in the Northwestern United States, 2006-2012.2006-2012 年美国西北部美国印第安人/阿拉斯加原住民的丙型肝炎相关死亡率。
Public Health Rep. 2020 Jan;135(1):66-73. doi: 10.1177/0033354919887748. Epub 2019 Nov 25.
5
Vaccination Status of Alaska Native Persons With Hepatitis A Virus Infection-Alaska, 1996-2018.甲型肝炎病毒感染的阿拉斯加原住民的疫苗接种状况-阿拉斯加，1996-2018 年。
Clin Infect Dis. 2021 Jun 15;72(12):2212-2214. doi: 10.1093/cid/ciaa1102.
6
Newly Reported Chronic Hepatitis C Among Adults - Alaska, 2016-2023.2016 - 2023年阿拉斯加成年人中新报告的慢性丙型肝炎
MMWR Morb Mortal Wkly Rep. 2025 Mar 27;74(10):161-166. doi: 10.15585/mmwr.mm7410a1.
7
Childhood cancer among Alaska Natives.阿拉斯加原住民中的儿童癌症。
Pediatrics. 2003 Nov;112(5):e396. doi: 10.1542/peds.112.5.e396.
8
The changing epidemiology and aetiology of hepatocellular carcinoma from 1969 through 2013 in Alaska Native people.1969 年至 2013 年期间阿拉斯加原住民人群中肝细胞癌的流行病因学变化。
Liver Int. 2016 Dec;36(12):1829-1835. doi: 10.1111/liv.13173. Epub 2016 Jun 16.
9
Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.格鲁吉亚消除丙型肝炎计划的进展与挑战
J Hepatol. 2020 Apr;72(4):680-687. doi: 10.1016/j.jhep.2019.11.019. Epub 2019 Dec 4.
10
Results of interferon-based treatments in Alaska Native and American Indian population with chronic hepatitis C.阿拉斯加原住民和美国印第安人慢性丙型肝炎患者基于干扰素治疗的结果。
Int J Circumpolar Health. 2016 Mar 29;75:30696. doi: 10.3402/ijch.v75.30696. eCollection 2016.
引用本文的文献
1
HCC surveillance in hepatitis C: A longitudinal algorithm improves alpha-fetoprotein screening.丙型肝炎中的肝细胞癌监测：一种纵向算法可改善甲胎蛋白筛查。
Hepatol Commun. 2025 May 23;9(6). doi: 10.1097/HC9.0000000000000719. eCollection 2025 Jun 1.
2
The impact of health insurance on hypertension care: a household fixed effects study in India.医疗保险对高血压治疗的影响：印度家庭固定效应研究。
BMC Public Health. 2024 Aug 22;24(1):2287. doi: 10.1186/s12889-024-19759-1.
3
The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national 'Happy Breathing' Programme.中国慢性阻塞性肺疾病的照护级联：一项针对国家“快乐呼吸”项目入组时个体水平数据的横断面研究。
EClinicalMedicine. 2024 Jul 16;74:102597. doi: 10.1016/j.eclinm.2024.102597. eCollection 2024 Aug.
4
Hepatitis C Cascades: Data to Inform Hepatitis C Elimination in the United States.丙型肝炎传播链：为美国消除丙型肝炎提供信息的数据。
Public Health Rep. 2023 Sep 5:333549231193508. doi: 10.1177/00333549231193508.
5
Understanding the Changing Landscape of Health Disparities in Chronic Liver Diseases and Liver Cancer.了解慢性肝病和肝癌中健康差距的变化态势。
Gastro Hep Adv. 2023;2(4):505-520. doi: 10.1016/j.gastha.2022.12.001. Epub 2022 Dec 15.
6
The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population.美国商业保险人群在直接抗病毒药物时代的丙型肝炎治疗流程
Open Forum Infect Dis. 2022 Sep 2;9(9):ofac445. doi: 10.1093/ofid/ofac445. eCollection 2022 Sep.
7
The Alaska Native/American Indian experience of hepatitis C treatment with sofosbuvir-based direct-acting antivirals.阿留申原住民/美洲印第安人使用索磷布韦为基础的直接作用抗病毒药物治疗丙型肝炎的体验。
PLoS One. 2021 Dec 2;16(12):e0260970. doi: 10.1371/journal.pone.0260970. eCollection 2021.
8
Time to HCV Treatment Disfavors Patients Living with HIV/HCV Co-infection: Findings from a Large Urban Tertiary Center.感染 HIV/HCV 合并感染的患者接受 HCV 治疗的时间不利：来自大型城市三级中心的研究结果。
J Racial Ethn Health Disparities. 2022 Oct;9(5):1662-1669. doi: 10.1007/s40615-021-01105-5. Epub 2021 Jul 12.
9
Low Uptake of Direct-acting Antiviral Therapy Among Hepatitis C Patients With Advanced Liver Disease and Access to Care, 2014-2017.2014-2017 年，有先进肝病治疗途径的丙型肝炎患者对直接作用抗病毒治疗的接受率低。
J Clin Gastroenterol. 2021 Jan;55(1):77-83. doi: 10.1097/MCG.0000000000001344.
本文引用的文献
1
Achievement of hepatitis C cascade of care milestones: a population-level analysis in Alberta, Canada.实现丙型肝炎关怀的各个里程碑：加拿大艾伯塔省的人群水平分析。
Can J Public Health. 2019 Dec;110(6):714-721. doi: 10.17269/s41997-019-00234-z. Epub 2019 Jun 20.
2
Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system.利用电子健康记录消除丙型肝炎：在大型综合医疗保健系统中的筛查。
PLoS One. 2019 May 23;14(5):e0216459. doi: 10.1371/journal.pone.0216459. eCollection 2019.
3
Curing Hepatitis C Virus Infection: Best Practices From the U.S. Department of Veterans Affairs.治愈丙型肝炎病毒感染：美国退伍军人事务部的最佳实践。
Ann Intern Med. 2017 Oct 3;167(7):499-504. doi: 10.7326/M17-1073. Epub 2017 Sep 26.
4
Risk of end-stage liver disease, hepatocellular carcinoma, and liver-related death by fibrosis stage in the hepatitis C Alaska Cohort.阿拉斯加丙型肝炎队列中终末期肝病、肝细胞癌及肝脏相关死亡风险与纤维化分期的关系
Hepatology. 2017 Jul;66(1):37-45. doi: 10.1002/hep.29115. Epub 2017 May 22.
5
Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.丙型肝炎病毒3型感染是终末期肝病、肝细胞癌和肝脏相关死亡的独立危险因素。
Clin Gastroenterol Hepatol. 2017 Mar;15(3):431-437.e2. doi: 10.1016/j.cgh.2016.10.012. Epub 2016 Oct 17.
6
The Cascade of Care for an Australian Community-Based Hepatitis C Treatment Service.澳大利亚社区丙型肝炎治疗服务的护理流程
PLoS One. 2015 Nov 12;10(11):e0142770. doi: 10.1371/journal.pone.0142770. eCollection 2015.
7
Toward a more accurate estimate of the prevalence of hepatitis C in the United States.迈向对美国丙型肝炎患病率更准确的估计。
Hepatology. 2015 Nov;62(5):1353-63. doi: 10.1002/hep.27978. Epub 2015 Aug 25.
8
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.丙型肝炎指南：美国肝病研究学会-美国感染病学会关于丙型肝炎病毒感染成人检测、管理及治疗的建议
Hepatology. 2015 Sep;62(3):932-54. doi: 10.1002/hep.27950. Epub 2015 Aug 4.
9
Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies.消除丙型肝炎病毒感染与肝细胞癌的发生：观察性研究的荟萃分析。
Ann Intern Med. 2013 Mar 5;158(5 Pt 1):329-37. doi: 10.7326/0003-4819-158-5-201303050-00005.
10
Institute of Medicine recommendations for the prevention and control of hepatitis B and C.美国医学研究所关于乙型肝炎和丙型肝炎预防和控制的建议。
Hepatology. 2010 Mar;51(3):729-33. doi: 10.1002/hep.23561.
Zotero 插件